Bassem Razzouk
Overview
Explore the profile of Bassem Razzouk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
165
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Klein K, Beverloo H, Zimmermann M, Raimondi S, von Neuhoff C, de Haas V, et al.
Pediatr Blood Cancer
. 2021 Sep;
69(1):e29341.
PMID: 34532968
Background: In addition to treatment response, cytogenetic and molecular aberrations are the most important prognostic factors in children with de novo acute myeloid leukemia (AML). However, little is known about...
2.
Creutzig U, Zimmermann M, Dworzak M, Gibson B, Tamminga R, Abrahamsson J, et al.
Haematologica
. 2014 Apr;
99(9):1472-8.
PMID: 24763401
The prognostic significance of early response to treatment has not been reported in relapsed pediatric acute myeloid leukemia. In order to identify an early and easily applicable prognostic factor allowing...
3.
Roberts S, Wells G, Gandhi N, York N, Maron G, Razzouk B, et al.
Support Care Cancer
. 2012 Jan;
20(10):2589-94.
PMID: 22278307
Background: Despite recent studies failing to demonstrate the value of routine chest radiography (CXR) in the initial evaluation of the febrile neutropenic patient with cancer, this screening test is advocated...
4.
Bonate P, Cunningham C, Gaynon P, Jeha S, Kadota R, Lam G, et al.
Cancer Chemother Pharmacol
. 2010 Jun;
67(4):875-90.
PMID: 20582417
Clofarabine for injection is a second-generation nucleoside analog approved in the United States (Clolar(®)) and Europe (Evoltra(®)) for the treatment of pediatric relapsed or refractory acute lymphoblastic leukemia. This report...
5.
Jeha S, Razzouk B, Rytting M, Rheingold S, Albano E, Kadota R, et al.
J Clin Oncol
. 2009 Aug;
27(26):4392-7.
PMID: 19652076
Purpose: To determine the efficacy and safety of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia (AML). Patients And Methods: A phase II, open-label, multicenter study was...
6.
Limb salvage surgery for children and adolescents with malignant bone tumors in a developing country
Haidar R, Sagghieh S, Muwakitt S, Mumtaz G, Akel S, Kamzoul R, et al.
Pediatr Blood Cancer
. 2008 Aug;
51(6):787-91.
PMID: 18680147
Purpose: To describe the 5-year experience of a multidisciplinary limb salvage program for children and adolescents with malignant bone tumors in Lebanon. Patients And Methods: Between January 2002 to February...
7.
Qaddoumi I, Nawaiseh I, Mehyar M, Razzouk B, Haik B, Kharma S, et al.
Pediatr Blood Cancer
. 2008 Feb;
51(2):241-4.
PMID: 18300320
Background: This study evaluated the outcome of retinoblastoma patients, when employing a telemedicine-based twinning program in Jordan. Procedure: This cohort study included patients at the King Hussein Cancer Centre (KHCC;...
8.
Hasle H, Alonzo T, Auvrignon A, Behar C, Chang M, Creutzig U, et al.
Blood
. 2007 Feb;
109(11):4641-7.
PMID: 17299091
Monosomy 7 (-7) and deletion 7q \del(7q)] are rare in childhood acute myeloid leukemia (AML). We retrospectively collected data on 258 children with AML or refractory anemia with excess blasts...
9.
Muwakkit S, Rodriguez-Galindo C, El Samra A, Khoury R, Akel S, Mroueh S, et al.
Pediatr Blood Cancer
. 2006 Mar;
47(5):636-8.
PMID: 16544294
Malignant peripheral nerve sheath tumors (MPNST) are uncommon in children and almost half of the cases occur in patients with neurofibromatosis 1 (NF1). We report a child with a primary...
10.
Bonate P, Craig A, Gaynon P, Gandhi V, Jeha S, Kadota R, et al.
J Clin Pharmacol
. 2004 Oct;
44(11):1309-22.
PMID: 15496649
The population pharmacokinetics of plasma clofarabine and intracellular clofarabine triphosphate were characterized in pediatric patients with acute leukemias. Traditional model-building techniques with NONMEM were used. Covariates were entered into the...